about
Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?Tumor angiogenesis: pericytes and maturation are not to be ignoredPoly(ADP-Ribose) Polymerase (PARP) Inhibitors for locally advanced or metastatic breast cancerActivation of rapid oestrogen signalling in aggressive human breast cancersMammary Development and Breast Cancer: A Wnt PerspectiveApproach to the Triple Negative Breast Cancer in New Drugs AreaCharacterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastasesThe Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to TherapyRevealing the Complexity of Breast Cancer by Next Generation SequencingInteractions between Myc and MondoA transcription factors in metabolism and tumourigenesisThe double face of Morgana in tumorigenesisOf mice and women: a comparative tissue biology perspective of breast stem cells and differentiationCurrent approaches in treatment of triple-negative breast cancerTargeting triple-negative breast cancer: optimising therapeutic outcomesCoordination of nutrient availability and utilization by MAX- and MLX-centered transcription networksTargeting SH2 domains in breast cancerGenomic profiling in triple-negative breast cancerEffective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression levelBiological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis.Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light RegimenBayesHammer: Bayesian clustering for error correction in single-cell sequencingA perspective on anti-EGFR therapies targeting triple-negative breast cancerOn metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancerKey Players in Choline Metabolic Reprograming in Triple-Negative Breast CancerRANKL/RANK: from bone loss to the prevention of breast cancerMolecular Classification of Triple-Negative Breast CancerThe LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancerDifferential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancerA phenotypic mouse model of basaloid breast tumorsTargeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptidesCucurbitacin E induces cell cycle G2/M phase arrest and apoptosis in triple negative breast cancerNovel inhibitors induce large conformational changes of GAB1 pleckstrin homology domain and kill breast cancer cellsA synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancerThe Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug SensitivityAntimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling PathwaysEvolutionary foundations for cancer biologyTubulin is a molecular target of the Wnt-activating chemical probeOpportunities for improving triple‐negative breast cancer outcomes: results of a population‐based studyGenome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis.
P2860
Q21261291-81A6A22A-2A9D-45BA-832F-60C0A9413A1CQ21296683-2A5B2696-C4B0-43E1-BA1B-C1FAEE47B6BBQ24188183-112C3BE6-A076-4E1C-A2DE-4AD4B7686C56Q24300885-9F02CD29-18A4-48F3-89EE-DA96A98D496CQ26740086-373E8DFB-8CEA-4B37-8E11-CA70AEF09C1EQ26744054-0571A030-87C6-4299-AC13-036E7186E827Q26750508-76616ABB-9727-4A7B-B0F7-CD9B09828AB3Q26768290-798283FD-14F7-4E4D-A2B9-5D199DAD838AQ26777395-DD29651A-0D01-43A7-BC19-112B22A06792Q26782728-69BA00F4-669D-487D-9F22-7CE7DBAA896FQ26783788-E2EBDFD1-6E0C-4CA8-A32B-6DE44C7FB2DCQ26796835-7AA76D59-2524-4107-ADCD-DB4846E0E150Q26801549-66EE99EE-8D7C-480E-A898-67DADD4ED54BQ26850892-3D63431C-7742-481F-A5DB-37A461ADC52EQ26853482-BB548C32-49AB-406A-A42D-91737BA14B23Q27014674-D13697ED-13C7-463B-8C6B-993015325D93Q27015775-EF36969C-48D8-471A-916F-DEEE03C0A9A4Q27300701-7DAE695F-F828-42AE-AD84-EC2181E976C9Q27311085-F0919856-E632-46D2-BD7C-97AE75C9A726Q27320934-A20DD3B2-EDE6-4354-9E91-E333B8C057E7Q27496610-3F4FB820-B8E4-4C33-A4EB-6DBE5400000AQ28069867-C6C711CC-C3A0-42D9-8156-AE5BCFF1C723Q28072798-58940D82-3049-41EA-93EF-53D26710EE88Q28074613-28A38FA5-ED04-4039-866B-552AC1EDDDF8Q28075004-1D695111-7A79-4EC0-863C-D156A1CEC410Q28076661-C92A6026-F04B-4DC7-B9D7-24D42F26F704Q28118941-4164E6E2-8930-4C32-9BD4-B1F4A5BD2BC5Q28477182-FEE16C93-F2C1-449C-AB66-C80CF1F6A990Q28480588-A468DA70-B1C6-4B45-8CB9-F62ECE6CA95BQ28486075-669A8CE2-6D4F-4DAC-9ECB-9BE0CFE35D04Q28541323-451DD6FD-F092-45F2-A62C-1DE81D6B206EQ28542983-BDD23BF9-5F41-4286-8713-2FFC798E332BQ28543036-3F56BAF7-8CC1-45EA-BC71-4A0034C3F9B5Q28545860-F9DDA176-B516-480F-8583-65FC43B57F6EQ28546871-58AE0697-AB30-4C9E-B760-987E15403B83Q28709090-9AD9FBF2-0E85-4C24-A14C-FBD0C31A701AQ28833737-C68175A8-B549-4A7D-A8FC-3F64FBDAFC83Q29248325-E7C39872-4E39-44DA-B308-2DFA8F21A159Q29417100-B70E8A80-B02D-4568-9D45-74B1EBA3C50EQ30009828-A1CFA1FB-D92E-459C-8588-C72BB8C2C94E
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Triple-Negative Breast Cancer
@ast
Triple-Negative Breast Cancer
@en
type
label
Triple-Negative Breast Cancer
@ast
Triple-Negative Breast Cancer
@en
prefLabel
Triple-Negative Breast Cancer
@ast
Triple-Negative Breast Cancer
@en
P3181
P356
P1476
Triple-Negative Breast Cancer
@en
P2093
Ian E. Smith
P304
P3181
P356
10.1056/NEJMRA1001389
P407
P577
2010-11-11T00:00:00Z